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Abstract 
Background: Current studies reporting on the risk of smoking and development of 
symptomatic diverticular disease have reported conflicting results.  
Objective: The aim of this study was to investigate the association between smoking 
and symptomatic diverticular disease. 
Design: Cohort study 
Settings: Swedish Construction Workers Cohort 1971-1993 
Patients: Construction workers in Sweden 
Main Outcome Measures: Development of symptomatic diverticular disease and 
complicated diverticular disease (abscess and perforation) as identified in the 
Swedish Hospital Discharge Register. Adjusted Relative Risks of symptomatic 
diverticular disease according to smoking status were estimated using Poisson 
regression. 
Results: In total the study included 232,685 men and 14,592 women. During follow-up 
3891 men and 318 women had a diagnosis of later symptomatic diverticular disease. 
In males, heavy smokers (≥15 cigarettes a day) had a 1.6 fold increased risk of 
developing symptomatic diverticular disease compared to non-smokers (Adjusted 
Relative Risk 1.56, 95% CI 1.42-1.72). There was evidence of a dose-response 
relationship as moderate and ex-smokers had a 1.4 and 1.2 fold increased risk 
compared to non-smokers (Adjusted Relative Risk 1.39, 95% CI 1.27-1.52 and 
Adjusted Relative Risk 1.14, 95% CI 1.04-1.27). These relationships were similar in 
females but the risk estimates were less precise due to smaller numbers. Male ever-
smokers had a 2.6 fold increased risk of developing complicated diverticular disease 
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(perforation/abscess) compared to non-smokers (Adjusted Relative Risks 2.73, 95% 
CI 1.69-4.41).  
Limitations: We were unable to account for other confounding variables such as 
comorbidity, prescription medication or lifestyle factors. 
Conclusions: Smoking is associated with symptomatic diverticular disease in both 
males and females and associated with an increased risk of developing complicated 
diverticular disease. 
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Introduction 
Diverticular disease and its associated complications such as acute diverticulitis 
place a significant burden on health care services1. This burden is expected to 
increase as the population ages2 with an already reported increase in the occurrence 
of the most serious complication perforation3, 4 and hospitalisation for acute 
diverticulitis5. Given these increases there has been interest in possible aetiological 
factors that could be modified to prevent these complications such as smoking6. 
There are biologically plausible reasons why tobacco use may be important in the 
pathogenesis of symptomatic disease as tobacco use impairs immune function, 
alters gut transit times, reduces blood flow and is associated with other intestinal 
inflammatory conditions7-9. A small retrospective study of 80 patients reported an 
association between smoking and an increased risk of diverticular complications10. A 
further small retrospective study reported an increased risk of stricture and 
perforation in patients undergoing elective colectomy for diverticular disease among 
smokers11. A larger population-based study of females reported a 1.23 fold 
increased risk (Relative risks (RR) 1.23, 95% CI 0.99-1.52) in current smokers of 
symptomatic diverticular disease when accounting for other confounding factors 
compared to non-smokers. The study also reported a greater risk of developing a 
perforation or abscess in current smokers compared to non-smokers (RR 1.89, 95% 
CI 1.15 to 3.10)12. However a study of the American Health Care Professionals 
(AHCP) cohort found no increased association between smoking and symptomatic 
diverticular disease when accounting for other confounding factors in males13.  
Current studies therefore do not provide population-based evidence of an 
association between smoking and symptomatic diverticular disease and have failed 
to demonstrate a dose-response relationship. The aim of this study was to assess 
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the relationship between smoking and development of symptomatic and complicated 
diverticular disease in a cohort of Swedish construction workers.
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Materials and Methods 
Patients and data sources 
The Swedish construction workers cohort is a population-based prospective cohort 
of 389,132 individuals of whom 369,174 were men and 19,418 were women14, 15. 
They had participated in health examinations from 1971-1993. On entry to the 
cohort, data were collected on smoking, occupation description and Body Mass 
Index (BMI) by administration of a questionnaire. Through the personal identity 
number16 we linked these data with data on hospitalisation for acute diverticulitis and 
complicated diverticular disease (diverticular abscess formation and perforation) 
from the Swedish Hospital Discharge Register. The baseline examination data were 
taken as the baseline data for the current study. Persons with unknown BMI or 
unknown smoking habits were excluded (n=80,451) as were those born before 1908 
(n=1,038), i.e. older than 79 years in 1987 as were those who died or emigrated 
before 1987 (n=20,824).  
Follow up 
Study follow up started from first recorded health examination and continued until 
death or December 2013. National coverage of the Swedish Hospital Discharge 
Register became complete from 1987 we therefore undertook a sensitivity analysis 
which included only those having health examinations between 1987-1993 as a start 
date to the end of follow up to ensure the relationships observed remained. 
Outcome Definition 
Hospitalisation for symptomatic diverticular disease was defined as any patient with 
a World Health Organization International Classification of Diseases (ICD) code for 
diverticulitis K57, 562 (ICD 10) and 562 (ICD 9). Perforated diverticular disease and 
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diverticular abscess were defined as complicated diverticular disease using ICD-10 
code K57.0, K57.2, K57.4, K57.6 or K57.8 and restricted to cases occurring 1997 to 
2013. The first outcome noted in the register for symptomatic or complicated disease 
was used in the analyses.  
Exposures 
We categorized smoking into four groups of non-smokers, ex-smokers, moderate 
(≤14 cigarettes per day or equivalent), and heavy smokers (≥15 cigarettes per day). 
A previous review of smoking data at the first and second health examination (2–3 
years apart) among 18,593 subjects in the “Bygghälsan” cohort found a 89% perfect 
match with data17. Inconsistencies regarding never-smoking status (study 
participants first indicated that they were current/former smokers in one 
questionnaire and then reported never-smoking in the second questionnaire) were 
reported for 2.7% 17. 
We categorized BMI into 18.5-19.9 kg/m2, 20.0-24.9 kg/m2, 25-29.9 kg/m2, 30-34.9 
kg/m2, and ≥35 kg/m2. This information was recorded from the first visit of the patient 
at baseline. As a marker for socioeconomic status we used job description dividing 
the cohort into office workers, foremen, skilled workers and unskilled/semi-skilled 
workers. Men with unspecified job title were excluded from analysis (N=39,532), 
while the majority of women with manual jobs had unspecified job title and were 
included in “unskilled/semi-skilled” category. All workers were employed in the 
construction industry.  
Statistical Analysis 
Person-years of follow up were calculated for each person from year of health 
examination within the construction worker service through 31 December 2013, 
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symptomatic diverticular disease, death or emigration, whichever occurred first. The 
person-years were stratified for age (10-year age strata), gender, BMI, 
socioeconomic status, tobacco smoking and lag-time. We studied age intervals from 
20 to 79 years for men, but due to few cases in young women we restricted that 
analysis to 40-79 years in women. Lag-time, i.e. the time between health 
examination and time of follow- up were categorized in 10 year classes (0-9, 10-19, 
20-29, 30+). 
Relative risks were estimated by Negative binomial regression analysis and 95% 
confidence intervals were calculated by standard errors. We planned a sensitivity 
analysis for those examined between 1987 and 1993 when coverage of the inpatient 
register became universal. We used statistics software SAS® 9.3 (SAS Institute, 
Cary, North Carolina, USA) to perform the statistical tests. P values <0.05 were 
considered statistically significant and all P values shown are two sided. 
Ethics 
The study was approved by the Regional Ethical Review Board in Umea (2014-195-
32M) and the board of the Swedish construction workers cohort. 
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Results 
Demographics of cohort 
In total the study included 232,685men and 14,592 women.  We identified 4,209 
individuals with a diagnosis of symptomatic diverticular disease with 3,891 males 
and 318 females. The median total follow up time was 30 years for men and 29 
years for women. Men were less likely to develop symptomatic diverticular disease 
than females when accounting for age, BMI, smoking, lag-time and socioeconomy 
(adjusted RR 0.68 95% CI 0.59-0.78).  The baseline demographics of the male and 
female smoking groups are shown in Tables 1.  
Smoking and symptomatic diverticular disease 
Heavy smoking in men was associated with an increased risk of developing 
symptomatic diverticular disease (RR 1.63, 95% CI1.43-1.85) (Table 2) compared to 
non-smokers. In the adjusted analysis this figure was attenuated but still represented 
a 1.6 fold increased risk (aRR 1.56, 95% CI 1.42-1.72). There was a dose-response 
relationship with those smoking less than 15 cigarettes a day and ex-smokers having 
a lower risk of developing symptomatic diverticular disease compared with non-
smokers (<15 cigarettes a day adjusted aRR 1.39, 95% CI 1.27-1.52 and ex-
smokers adjusted aRR 1.14, 95% CI 1.04-1.27). 
In females the number of cases were fewer and the precision of risk estimates lower. 
Only moderate smokers had a statistically increased risk of developing symptomatic 
diverticular disease with a 1.6 fold increase compared to non-smokers (aRR 1.64, 
95% CI 1.25-2.14)(Table 2).  
Smoking and complicated diverticular disease (perforation/abscess) 
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Examination of the association between smoking and complicated diverticular 
disease was not possible in females as there were too few cases. In male ever-
smokers we found an increased risk of diverticular abscess or perforation of 2.7 fold 
compared to non-smokers (aRR 2.73, 95% CI 1.69-4.41))(Table 3). There was again 
evidence of a dose-response relationship with heavy smokers having a 3.8 fold 
increase compared to non-smokers (adjusted HR 3.80, 95% CI 2.21-6.51) although 
the precision of this estimate was lower due to fewer outcomes. 
Sensitivity analysis of men examined from 1987-1993 
Restricting the analysis to those men with health examinations between 1987 and 
1993 demonstrated a similar relationship between smoking and symptomatic 
diverticular disease with heavy smokers having a 1.8 fold increased risk of 
symptomatic diverticular disease compared to non-smokers(aRR 1.79, 95%CI 1.43-
2.23). 
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Discussion 
We found that smoking is associated with an increased risk of developing 
symptomatic diverticular disease in both men and women. Those men smoking more 
than or equal to 15 cigarettes a day had a 1.6 fold increased risk of developing 
symptomatic diverticular disease requiring hospitalization compared to non-smokers. 
In men there was also a 2.6 fold increase risk in the development of complicated 
diverticular disease in ever-smokers compared to non-smokers.  
Two small retrospective studies have reported an increased risk of diverticular 
complications in smokers10, 11. These studies however did not report on the 
development of symptomatic disease. Two population-based studies have reported 
conflicting results as to the role of smoking in the development of symptomatic 
disease. Aldoori et al reported current smoking was not significantly associated with 
symptomatic diverticular disease (RR 1.25; 95% CI 0.75-2.09) however the cohort 
studied was formed of male health care workers only with only 10% of the cohort 
being current smokers13. The study also lacked power as the analysis of smoking 
was based on only 45 events as opposed to the 4209 events in our study.  A study 
reporting on the risk of symptomatic diverticular disease from the Swedish 
Mammography cohort reported a 1.26 fold increase in risk of symptomatic 
diverticular disease in current smokers compared to non-smokers and they were 
unable to report a dose-response relationship12. Our current estimates are greater 
than these with a 1.6 fold increase in risk of symptomatic disease in those smoking 
more than 15 cigarettes a day compared to non-smokers. We report for the first time 
a dose-response relationship with increasing risk of symptomatic diverticular disease 
with increasing frequency of tobacco use.  
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We found an increased risk of diverticular abscess or perforation in men who 
smoked. This risk was greatest in those who were heavy smokers. Women who 
smoke have been reported to have a 1.9 fold increased risk of diverticular abscess 
and perforation12. Those smoking greater than 10 cigarettes a day had the greatest 
increase in risk (RR 2.30 95% CI 1.26-4.20)12. Other studies have also shown an 
increased risk of perforation associated with smoking18, 19. 
This is a large cohort study with use of standardised questionnaires to prospectively 
collect data on smoking limiting the potential for recall bias. As we have used only 
the first questionnaire collected there is a possibility of non-differential 
misclassification of current and ex-smokers however previous work has reported that 
the data on smoking remained similar between the first and second health 
questionnaires which were administered 2-3 years apart in 89% of cases reviewed20. 
The diagnosis of symptomatic diverticular disease was made using ICD 10 and ICD 
9 coding. This has limited our ability to identify cases of acute diverticulitis as this is 
not included in the ICD 10 classification but we have been able to stratify into those 
with abscess/perforation and shown an increased risk of complicated disease in men 
who smoke. A review of NPR validation studies conducted by Ludvigsson et al,21 
concluded that the positive predictive value (PPV) varies based on the diagnosis but 
generally ranges between 85-95%. Furthermore a review of coding of symptomatic 
diverticular disease using the K572-9 code in 528 consecutive admissions to a single 
centre in Sweden found 95.8% of all cases to be correctly classified22.  We have not 
been able to account for comorbidity, dietary and life style factors. However prior 
small studies adjusting for these factors have shown they are only weak risk 
factors12, 13. Coverage of the inpatient register became universal in 1987 and our 
sensitivity analysis demonstrated broadly similar associations with our analysis of 
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those with a first examination performed from 1971-1993. We exclude older person 
(>79 years) and the association may different for persons of high age. All cases 
identified in this study required hospitalization for their diverticular disease. It is likely 
that some patients with symptomatic disease will have been treated as out patients 
or in the community and therefore the current study does not allow us to report on 
the association between smoking and symptomatic disease in this group. 
Our findings strengthen the hypothesis that smoking is associated with the 
development of symptomatic diverticular disease. Given these findings it may be 
advisable for patients diagnosed with colonic diverticulosis to abstain from smoking 
in order to reduce their risk of developing symptomatic disease.
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Table 1. Demographics of males and females by smoking 
classification 
  
  Non-Smokers Ex-Smokers 
Moderate 
Smokers 
Heavy 
Smokers 
Males 
    N 102486 36133 55807 38259 
Year of birth(SD) 1951.6 (16.4) 1938.1 (14.7) 1940.3 (15.7) 1946.3 (13.4) 
Mean BMI (kg/m2) (SD) 24.0 (3.1) 24.9 (3.1) 23.9 (3.0) 24.0 (3.2) 
Worker Level 
    Office worker (%) 3780 (3.7) 1597 (4.4) 1315 (2.4) 1403 (3.7) 
Forman (%) 9663 (9.4) 3947 (10.9) 4169 (7.5) 3717 (9.7) 
Skilled Worker (%) 76285 (74.4) 24576 (68.0) 40844 (73.2) 25531 (66.7) 
Unskilled/Semi-skilled (%) 12758 (12.4) 6013 16.6) 9479 (17.0) 7608 19.9) 
Females 
    N 7317 1349 3274 2652 
Year of birth(SD) 1945.3 (15.9) 1944.2 (11.9) 1945.4 (13.9) 1948.0 (12.1) 
Mean BMI (kg/m2)(SD) 23.6 (4.0) 23.7 (3.7) 22.7 (3.5) 23.0 (3.6) 
Worker Level 
    Office worker (%) 3254 (44.5) 672 (49.8) 1413 (43.2) 1046 (39.4) 
Forman (%) 331 (4.5) 22 (1.6) 59 (1.8) 68 (2.6) 
Skilled Worker (%) 359 (4.9) 33 (2.5) 154 (4.7) 183 (6.9) 
Unskilled/Semi-skilled (%) 3373 (46.1) 622 (46.1) 1648 (50.3) 1355 (51.1) 
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Table 2. All cases of symptomatic diverticular disease (SDD) in men and women examined 1971-93. 
  
Person-
years 
Cases of 
SDD Unadjusted RR (95% CI) Adjusted RR (95% CI)* 
Males 
    Tobacco-Smoking 
    Non-Smokers 2753953 1219 1 (ref) 1 (ref) 
Ex-smokers 849666 682 1.42 (1.24-1.63) 1.14 (1.04-1.27) 
Moderate smokers <15 cig/day 1308270 1146 1.62 (1.43-1.84) 1.39 (1.27-1.52) 
Heavy smokers >/=15 cig day 1004439 844 1.63 (1.43-1.85) 1.56 (1.42-1.72) 
Females 
    Tobacco-Smoking 
    Non-Smokers 163065 133 1 (ref) 1 (ref) 
Ex-smokers 31605 37 1.35 (0.86-2.11) 1.33 (0.92-1.92) 
Moderate smokers <15 cig/day 74170 97 1.64 (1.15-2.35) 1.64 (1.25-2.14) 
Heavy smokers >/=15 cig day 61689 51 0.97 (0.65-1.47) 1.12 (0.81-1.55) 
* Adjusted for age, BMI, lag-time and socioeconomic status 
 
 
   Table 3. Association of smoking with complicated diverticular disease (CDD) (abscess/perforation) 
  
Person-
years 
Cases of 
CDD Unadjusted RR (95% CI) Adjusted RR (95% CI) 
Tobacco-Smoking 
    Non-Smokers 1713459 25 1 (ref) 1 (ref) 
Ex-smokers 482036 17 1.43 (0.77-2.70) 1.55 (0.80-2.99) 
Moderate smokers <15 cig/day 742908 45 2.79 (1.70-4.59) 2.80 (1.64-4.77) 
Heavy smokers >/=15 cig day 599172 42 3.75 (2.28-6.16) 3.80 (2.21-6.51) 
* Adjusted for age, BMI, lag-time and socioeconomic status 
    
